SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor is trending due to recent policy moves aimed at driving down mortgage rates, which has ignited strong community optimism for a revitalized housing market. Investors are actively discussing the potential for increased transaction volume and a significant price appreciation, with many anticipating a move towards double-digit levels for the company's stock.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

ProShares Ultra Bloomberg Natural Gas (BOIL) is trending amid extreme volatility and a significant price decline, with many in the community citing aggressive market 'manipulation' or 'fkkery'. Despite some expectations for a 'polar payday' driven by potential colder weather, the leveraged ETF faces relentless selling pressure, prompting discussions of capitulation, impending reverse splits, and its inherent decay as it tracks natural gas futures.

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.

Aquestive Therapeutics Inc

Aquestive Therapeutics is trending following an FDA notification about deficiencies precluding labeling discussions for its Anaphylm drug, just weeks before its PDUFA date. While this news caused a significant stock drop, many in the community view it as an overreaction to minor "labeling semantics," asserting that the FDA would not engage in such detailed discussions if approval wasn't likely. The immediate focus is on how quickly these issues can be resolved for the potentially transformative needle-free epinephrine film, with the FDA confirming the review remains ongoing.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is trending after announcing a significant agreement with Meta to develop a 1.2-gigawatt power campus for AI data centers, driving conversation around the future of nuclear energy. This deal has ignited strong community debate over Oklo's speculative valuation, given its pre-revenue status, versus its long-term potential to address the escalating energy demands of the AI sector with advanced nuclear technology.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is buzzing following significant new agreements to secure vast amounts of long-term nuclear energy, a critical move to power its rapidly expanding data centers and burgeoning AI infrastructure. This strategic embrace of clean, reliable power is driving community conversation, highlighting the increasing energy demands of hyperscalers and sparking diverse opinions on its financial implications and impact on the broader nuclear sector.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is trending as the market increasingly recognizes small modular reactors (SMRs) as a vital solution for the escalating energy demands of AI data centers. Community discussions highlight NuScale's unique position as the sole NRC-approved SMR technology, with recent positive developments like a Virginia energy award for a NuScale simulator and broader U.S.-Japan nuclear investment commitments fueling both investor interest and debates over long-term valuation and potential dilution.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

Ondas Holdings is a primary discussion point following reports its subsidiary, Airobotics, secured a major contract for Israel's "Drone Hives" border security, amplified by broader expectations of increased defense spending. The community is split, with many anticipating significant upside in the burgeoning drone and autonomous systems sector, while others raise concerns about valuation and the specifics of defense contracts.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASP Isotopes is trending after securing all regulatory approvals for its Renergen acquisition, which expands its portfolio into helium and LNG alongside its core isotope business. The community is actively discussing this, alongside a recent "Overweight" rating from Cantor Fitzgerald, as ASPI aims to be a critical supplier of HALEU and specialized isotopes for the growing nuclear and tech sectors.

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.

Aptevo Therapeutics Inc

Aptevo Therapeutics (APVO) is trending following news of securing a $60 million equity line of credit, which some view as a critical funding boost for its pipeline while others fear it signals further dilution. The company's extremely low share float after a recent reverse split has ignited significant community discussion around a potential short squeeze, despite ongoing concerns about historical shareholder value and the nature of the new financing.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals (SPRY) is currently trending due to its Neffy nasal spray securing new global approvals, notably in China, coupled with robust Q3 revenue performance and significant non-dilutive funding. This has intensified community discussions around the stock's high short interest and potential for a squeeze, as investors weigh Neffy's first-mover advantage in the needle-free epinephrine market against competitive pressures and expanding applications like hives treatment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Palo Alto Networks, Inc. ( $PANW ) daily stock analysis by SpicyTrade https://youtu.be/sBP7mxe36s4?si=wQruKp4wpKsWcFsN

Palo Alto Networks, Inc. ( $PANW ) daily stock analysis by SpicyTrade Date :January 07, 2026 Please note: All stock analysis posted here is for information and entertainment purposes only. All stock analysis are based on daily closing orice of the stokcs and has nothing to do with the future price of the stock.